MARATTO

article · Data in Brief

Dataset on effect of cadmium and lead on chemical reactivity of selected heterocyclic compounds as potential dipeptidyl peptidase III inhibitors using insilico method

2025Open accessOsun State University

Abstract

The role played by heterocyclic compounds in drug design and discovery remain crucial globally. In this work, the effect of cadmium and lead were investigated on the chemical reactivity of selected heterocyclic compounds with potential anti-dipeptidyl peptidase III activity using insilico method. Various software such as Spartan 14 (for optimization), molecular operating environment (moe) (for induced fit docking) and ADMETSar (pharmacokinetic examination) were used to execute the investigations. Three descriptors (highest occupied molecular orbital energy (EHOMO); lowest unoccupied molecular orbital energy (ELUMO) and energy gap) were observed among others for selected compounds without any foreign attachment, selected compounds with cadmium and selected compounds with lead. The calculated descriptors revealed that cadmium had a great effect on compound 7 in term of HOMO energy and energy gap. Also, it was observed that cadmium altered the ability of compound 5 in term LUMO energy. The selected compounds were docked against dipeptidyl peptidase III and the scoring was reported. More so, pharmacokinetic examination of ligands with highest binding affinity was reported and compared to the report for the reference molecules.

Research topics

  • Computational Drug Discovery Methods
  • Neuropeptides and Animal Physiology
  • Peptidase Inhibition and Analysis

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.dib.2025.111481

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.